SCHEMBL5264014

SCHEMBL5264014

Cc1ccc2cc(Nc3cc(OC4CCN(C(=O)O)CC4)ncn3)ccc2n1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.46
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
DOT1L Q8TEK3 1/20 0.39
FLT3 P36888 3/20 0.38
CDK2 P24941 1/20 0.38
CDK6 Q00534 1/20 0.38
KDM1A O60341 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ERBB2 P04626 3/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
PDE10A Q9Y233 1/20 0.37
SCN9A Q15858 2/20 0.37
EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL389163 0.89 GPR119 (0.61) GPR119
SCHEMBL4720771 0.84 GPR119 (0.48) GPR119NPC1RAB9AFLT3CDK2
SCHEMBL13685341 0.81 GPR119 (0.53) GPR119FLT3CDK2CDK6ERBB2
SCHEMBL1830976 0.79 GPR119 (0.45) GPR119FLT3CDK2CDK6EGFR
SCHEMBL5188992 0.78 GPR119 (0.45) GPR119FLT3CDK2CDK6ERBB2
SCHEMBL1070555 0.78 GPR119 (0.47) GPR119FLT3CDK2CDK6EGFR
SCHEMBL5046848 0.76 GPR119 (0.44) GPR119FLT3CDK2CDK6ERBB2
SCHEMBL3866032 0.74 GPR119 (0.48) GPR119FLT3CDK2CDK6ERBB2
SCHEMBL5048764 0.74 GPR119 (0.49) GPR119FLT3CDK2CDK6ERBB2
SCHEMBL5264283 0.73 GPR119 (0.62) GPR119FLT3CDK2CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756084-A2 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2007-02-28 EP claimed
WO-2005121121-A2 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2005-12-22 WO claimed